
|Articles|December 1, 2004
Seed migration unlikely to cause adverse events
Extraprostatic seed placement during prostate brachytherapy frequently results in seed migration to the thorax. However, this occurrence apparently does not influence dosimetry or cause adverse effects, suggest results of a Mayo Clinic series.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests potential diuretic effect with nadofaragene firadenovec
2
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
3
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











